Benzonitryl and nitrobenzyl derivatives that modulate androgen receptors

Benzonitryl and nitrobenzyl derivatives that modulate androgen receptors

This invention relates to benzonitryl and nitrobenzyl derivatives that are modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors, and also to the methods for the making and use of such compounds. These compounds are useful, for example, in the treatment or prophylaxis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Turnbull, Philip Stewart, Larkin, Andrew Lamont, Kaldor, Istvan, Cadilla, Rodolfo, Cowan, David John, Stewart, Eugene Lee
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Turnbull, Philip Stewart
Larkin, Andrew Lamont
Kaldor, Istvan
Cadilla, Rodolfo
Cowan, David John
Stewart, Eugene Lee
description This invention relates to benzonitryl and nitrobenzyl derivatives that are modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors, and also to the methods for the making and use of such compounds. These compounds are useful, for example, in the treatment or prophylaxis of conditions or disorders that respond to selective androgen receptor modulation.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07834063</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07834063</sourcerecordid><originalsourceid>FETCH-uspatents_grants_078340633</originalsourceid><addsrcrecordid>eNrjZPBwSs2rys_LLCmqzFFIzEtRADHzk4CCQH5KalFmWWJJZllqsUJJRmKJQm5-SmlOYkkqSGVRfnpqnkJRanJqQUl-UTEPA2taYk5xKi-U5mZQcHMNcfbQLS0uAOrIKymOTy9KBFEG5hbGJgZmxsZEKAEA-5U2ZQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Benzonitryl and nitrobenzyl derivatives that modulate androgen receptors</title><source>USPTO Issued Patents</source><creator>Turnbull, Philip Stewart ; Larkin, Andrew Lamont ; Kaldor, Istvan ; Cadilla, Rodolfo ; Cowan, David John ; Stewart, Eugene Lee</creator><creatorcontrib>Turnbull, Philip Stewart ; Larkin, Andrew Lamont ; Kaldor, Istvan ; Cadilla, Rodolfo ; Cowan, David John ; Stewart, Eugene Lee ; GlaxoSmithKline LLC</creatorcontrib><description>This invention relates to benzonitryl and nitrobenzyl derivatives that are modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors, and also to the methods for the making and use of such compounds. These compounds are useful, for example, in the treatment or prophylaxis of conditions or disorders that respond to selective androgen receptor modulation.</description><language>eng</language><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7834063$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,778,800,883,64024</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7834063$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Turnbull, Philip Stewart</creatorcontrib><creatorcontrib>Larkin, Andrew Lamont</creatorcontrib><creatorcontrib>Kaldor, Istvan</creatorcontrib><creatorcontrib>Cadilla, Rodolfo</creatorcontrib><creatorcontrib>Cowan, David John</creatorcontrib><creatorcontrib>Stewart, Eugene Lee</creatorcontrib><creatorcontrib>GlaxoSmithKline LLC</creatorcontrib><title>Benzonitryl and nitrobenzyl derivatives that modulate androgen receptors</title><description>This invention relates to benzonitryl and nitrobenzyl derivatives that are modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors, and also to the methods for the making and use of such compounds. These compounds are useful, for example, in the treatment or prophylaxis of conditions or disorders that respond to selective androgen receptor modulation.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZPBwSs2rys_LLCmqzFFIzEtRADHzk4CCQH5KalFmWWJJZllqsUJJRmKJQm5-SmlOYkkqSGVRfnpqnkJRanJqQUl-UTEPA2taYk5xKi-U5mZQcHMNcfbQLS0uAOrIKymOTy9KBFEG5hbGJgZmxsZEKAEA-5U2ZQ</recordid><startdate>20101116</startdate><enddate>20101116</enddate><creator>Turnbull, Philip Stewart</creator><creator>Larkin, Andrew Lamont</creator><creator>Kaldor, Istvan</creator><creator>Cadilla, Rodolfo</creator><creator>Cowan, David John</creator><creator>Stewart, Eugene Lee</creator><scope>EFH</scope></search><sort><creationdate>20101116</creationdate><title>Benzonitryl and nitrobenzyl derivatives that modulate androgen receptors</title><author>Turnbull, Philip Stewart ; Larkin, Andrew Lamont ; Kaldor, Istvan ; Cadilla, Rodolfo ; Cowan, David John ; Stewart, Eugene Lee</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_078340633</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2010</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Turnbull, Philip Stewart</creatorcontrib><creatorcontrib>Larkin, Andrew Lamont</creatorcontrib><creatorcontrib>Kaldor, Istvan</creatorcontrib><creatorcontrib>Cadilla, Rodolfo</creatorcontrib><creatorcontrib>Cowan, David John</creatorcontrib><creatorcontrib>Stewart, Eugene Lee</creatorcontrib><creatorcontrib>GlaxoSmithKline LLC</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Turnbull, Philip Stewart</au><au>Larkin, Andrew Lamont</au><au>Kaldor, Istvan</au><au>Cadilla, Rodolfo</au><au>Cowan, David John</au><au>Stewart, Eugene Lee</au><aucorp>GlaxoSmithKline LLC</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Benzonitryl and nitrobenzyl derivatives that modulate androgen receptors</title><date>2010-11-16</date><risdate>2010</risdate><abstract>This invention relates to benzonitryl and nitrobenzyl derivatives that are modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors, and also to the methods for the making and use of such compounds. These compounds are useful, for example, in the treatment or prophylaxis of conditions or disorders that respond to selective androgen receptor modulation.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_07834063
source USPTO Issued Patents
title Benzonitryl and nitrobenzyl derivatives that modulate androgen receptors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T14%3A46%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Turnbull,%20Philip%20Stewart&rft.aucorp=GlaxoSmithKline%20LLC&rft.date=2010-11-16&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07834063%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true